Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Change in Acquisitions & Divestments (2017 - 2025)

Anaptysbio (ANAB) has disclosed Change in Acquisitions & Divestments for 9 consecutive years, with $73.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Acquisitions & Divestments fell 19.89% year-over-year to $73.5 million, compared with a TTM value of $424.5 million through Dec 2025, down 10.84%, and an annual FY2025 reading of $424.5 million, down 10.84% over the prior year.
  • Change in Acquisitions & Divestments was $73.5 million for Q4 2025 at Anaptysbio, down from $123.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $149.2 million in Q4 2022 and bottomed at $9.6 million in Q1 2022.
  • Average Change in Acquisitions & Divestments over 5 years is $95.9 million, with a median of $101.1 million recorded in 2022.
  • The sharpest move saw Change in Acquisitions & Divestments plummeted 84.8% in 2022, then soared 1294.24% in 2023.
  • Year by year, Change in Acquisitions & Divestments stood at $25.5 million in 2021, then skyrocketed by 485.29% to $149.2 million in 2022, then dropped by 22.44% to $115.8 million in 2023, then fell by 20.75% to $91.7 million in 2024, then decreased by 19.89% to $73.5 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for ANAB at $73.5 million in Q4 2025, $123.0 million in Q3 2025, and $90.6 million in Q2 2025.